Classical swine fever is a notifiable disease of pigs. The causative agent, classical swine fever virus (CSFV), is highly contagious and causes mild to severe haemorrhagic disease depending on the virulence of the strain. The RNA genome of CSFV is translated as a single polyprotein that is processed to yield 12 proteins. Like other pestiviruses, the first protein to be translated is the Nterminal autoprotease termed N pro . A novel pestiviral protein with no known cellular homologues, N pro antagonizes type I interferon (IFN) induction by binding and targeting the transcription factor IFN regulatory factor 3 (IRF-3) for ubiquitin-dependent proteasomal degradation. In this study, CSFV-infected PK-15 cells and stable cell lines were used to show that N pro is itself an unstable protein that is targeted for proteasomal degradation in a ubiquitin-dependent manner. In addition, N pro is not degraded as a direct consequence of its ability to interact with IRF-3 or to target IRF-3 for proteasomal degradation.
Pestiviruses such as classical swine fever virus (CSFV) encode a novel N-terminal autoprotease termed N pro (Lindenbach et al., 2007; Thiel et al., 1996) . CSFV and the related bovine viral diarrhea virus (BVDV) prevent host production of type I interferon (IFN) (Baigent et al., 2002 (Baigent et al., , 2004 Bensaude et al., 2004; Charleston et al., 2001; Ruggli et al., 2003; Schweizer & Peterhans, 2001) . This is facilitated in part by the N-terminal protease (N pro ) protein, which targets IFN regulatory factor 3 (IRF-3) for proteasomal degradation (Bauhofer et al., 2007; Chen et al., 2007; Hilton et al., 2006; Seago et al., 2007) . In BVDVinfected cattle, the antagonism of the innate immune response by N pro , in combination with the E rns product, is essential in blocking type I IFN induction and establishing persistent infection in the natural host (Meyers et al., 2007) .
The positive-stranded RNA genome of CSFV is translated as a polyprotein, from which N pro cleaves itself. However, the protease activity of N pro is not required for the inhibition of IFN-a/b induction or the targeting of IRF-3 for degradation (Gil et al., 2006; Hilton et al., 2006; Ruggli et al., 2009) . The mechanism by which N pro orchestrates the proteasomal degradation of IRF-3 is as yet unknown, but involves the ubiquitination of IRF-3 (Chen et al., 2007; Hilton et al., 2006) . N pro has been shown to interact with IRF-3; however, it is unclear whether this is a direct interaction or mediated through another protein (Bauhofer et al., 2007; Chen et al., 2007; Ruggli et al., 2009) . N pro does not appear to inhibit the general phosphorylation of IRF-3 or interfere with the nuclear localization of a constitutively active form of IRF-3 (Bauhofer et al., 2007) . To date, no cellular homologues of N pro have been identified and N pro does not appear to contain sequence similarities to other viral proteins that also bind IRF-3 and orchestrate its proteasomal degradation, such as rotavirus non-structural protein 1 (NSP1) (Bauhofer et al., 2007) .
Here, we present data to show that the N pro product of CSFV is itself degraded rapidly by the proteasome in a manner that is dependent upon an intact ubiquitination system. Furthermore, N pro is not degraded as a direct consequence of its ability to interact with IRF-3 or to target IRF-3 for proteasomal degradation.
To generate PK-15 cells constitutively expressing the CSFV N pro product from a human cytomegalovirus (CMV) immediate-early promoter, we constructed plasmids encoding either His-tagged or non-tagged N pro (Alfort strain) and containing the woodchuck post-transcriptional regulatory element (WPRE) (Donello et al., 1998) . WPRE has been shown to facilitate nucleocytoplasmic transport of RNA and acts on additional post-transcriptional mechanisms to stimulate expression of heterologous cDNAs (Mähönen et al., 2007; Popa et al., 2002; Zufferey et al., 1999) . Western blot analysis of cell extracts prepared from either stable cell line revealed barely detectable N pro protein levels. A previous study reported that PK-15 and SK-6 cell lines expressing an enhanced green fluorescent protein IP: 54.70.40.11
On: Fri, 21 Dec 2018 17:12:15 (EGFP)-N pro fusion protein under the control of the CMV promoter expressed 60 and 10 times less protein, respectively, than EGFP control lines (Ruggli et al., 2005) .
To investigate the stability of N pro , we treated two PK-15 single-cell lines with the proteasome inhibitor epoxomicin (Alexis Biochemicals) in the presence of the general caspase inhibitor ZVAD (BACHEM), the addition of which limited the apoptotic side effects of long-term epoxomicin treatment (Myung et al., 2001) . As shown in Fig. 1(a) , N pro and His-tagged N pro protein accumulated rapidly over a short period of time. Similar results were obtained using the proteasome inhibitor MG132 (Sigma) (see Fig. 1b-d ) and suggest that the N pro protein of CSFV is targeted for proteasomal degradation in PK-15 cells (Myung et al., 2001) . The proteasome inhibitors MG132 and epoxomicin were used interchangeably in this study because of their equal abilities to prevent N pro turnover.
In order to determine how quickly CSFV-encoded N pro is turned over within infected PK-15 cells, we used the translation inhibitor cycloheximide (CHX) (Sigma) in conjunction with Western blot analysis. Fig. 1(b) shows that CSFV-encoded N pro is a short-lived protein in PK-15 cells, with a half-life of about 4 h. In agreement with the data obtained using stable cell lines, the proteasome inhibitor MG132, but not the cysteine protease inhibitor E64D (Sigma), was able to prevent N pro turnover in CSFV-infected Fig. 1 . N pro is targeted for proteasomal degradation. (a) PK-15 cells stably expressing N pro or His-N pro were incubated with epoxomicin for the indicated periods of time and whole-cell extracts were analysed by Western blotting for N pro and c-tubulin (loading control). (b) PK-15 cells were infected (m.o.i. of 1) with CSFV (Alfort) for 18 h and treated with cycloheximide (CHX) for the indicated periods of time, and whole-cell extracts were analysed by Western blotting for N pro , c-tubulin and CSFV E2. The fold intensity for N pro , as determined by densitometry analysis of Western blots using Bio-Rad software (Quantity One), is shown. MG132 and E64D were used where indicated as positive and negative inhibitors of the proteasome, respectively. (c) PK-15 cells stably expressing His-N pro were mock-infected or infected (m.o.i. of 1) with CSFV (Alfort) and, where indicated, treated with MG132 for 24 h. Whole-cell extracts were then analysed by Western blotting for N pro and c-tubulin. His-N pro (*) and CSFV-encoded N pro (**) are indicated. (d) PK-15 cells stably expressing N pro were incubated with epoxomicin or MG132 for 8 h and nuclear and cytoplasmic extracts were analysed by Western blotting for N pro and c-tubulin, as well as for histone H1 and a-tubulin (nuclear and cytoplasmic markers, respectively). (e) PK-15 cells stably expressing N pro were incubated with CHX for the indicated period of time and nuclear and cytoplasmic extracts were analysed by Western blotting for N pro and c-tubulin, histone H1 and a-tubulin. Unless indicated, all control samples were treated with DMSO. cells. Similarly, the serine protease inhibitor PMSF (Sigma) was unable to prevent N pro degradation (data not shown).
Next, we examined whether the presence of the other CSFV proteins could influence the level of N pro expressed in a stable cell line. PK-15 cells expressing His-tagged N pro were infected with CSFV and then left untreated or treated with proteasome inhibitor. Fig. 1(c) shows that CSFV infection led to only a small increase of His-tagged N pro protein in comparison to mock infection, suggesting that the other CSFV proteins do not modulate N pro stability significantly.
Components of the proteasome are localized throughout the cell in both the cytoplasm and the nucleus (Coux et al., 1996) . We have shown recently that N pro also localizes to both the cytoplasm and the nucleus of CSFV-infected cells and cell lines stably expressing N pro (Doceul et al., 2008) .
To determine whether proteasome inhibitors lead to an accumulation of N pro in a particular compartment, cytoplasmic and nuclear extracts prepared from a His-N pro single-cell line treated with MG132 or epoxomicin were analysed by Western blot. Likewise, to determine whether N pro degradation leads to the depletion of N pro in either compartment, the same cell line was treated with CHX for different periods of time and extracts were analysed. Fig. 1(d) shows that N pro protein accumulated in both the cytoplasm and the nuclei of cells in which the proteasome activity had been inhibited. Fig. 1(e) shows that, after 2 h inhibition of protein translation by CHX, a comparable decrease of N pro levels in both compartments was observed. It is conceivable that N pro , an approximately 19 kDa protein, is degraded in the cytoplasm and not in the nucleus, but diffuses passively between compartments following its accumulation or degradation.
Most proteasomal substrates are ubiquitinated before being degraded. CSFV N pro (Alfort/187 strain, GenBank accession no. X87939) contains 13 lysine residues, one or more of which may be targeted for ubiquitination. To investigate whether N pro is ubiquitinated prior to its degradation, PK-15 cells stably expressing His-N pro were treated with MG132 before ubiquitinated proteins were precipitated from cell extracts by using a commercial kit (Ubiquitin Enrichment kit; Pierce). Analysis of the precipitated samples by Western blotting revealed a ladder of highermolecular-mass forms of N pro from around 30 to 50 kDa, suggesting that N pro is indeed targeted for ubiquitination ( Fig. 2a ). Non-ubiquitinated N pro was also identified in the ubiquitin-enriched sample that was analysed and was presumably a consequence of co-precipitation with a ubiquitinated protein or the removal of ubiquitin by deubiquitinases. To provide more evidence that N pro turnover is reliant on an intact ubiquitination pathway, we used murine fibroblast ts20 cell lines stably expressing His-tagged or non-tagged N pro protein. The ts20 cell line inactivated and proteins can no longer be degraded by the ubiquitin-dependent proteasome pathway. Fig. 2(b) shows that, in two independent ts20 cell lines stably expressing N pro , the inhibition of ubiquitin-dependent proteasomal decay, either by a shift in temperature or by the addition of epoxomicin, led to a dramatic increase in the amount of N pro protein. These results confirm that an intact ubiquitin system is required for N pro turnover.
We next investigated whether the turnover of N pro is related directly to its ability to interact with and to target IRF-3 for ubiquitin-dependent proteasomal degradation. To do this, we utilized individual cell lines stably expressing N pro point mutants: PK-15 cell lines expressing N pro with either a cysteine to arginine mutation at position 112 (C 112 R) or an aspartic acid to asparagine mutation at position 136 (D 136 N), and a 3T3 cell line expressing N pro with a leucine to proline mutation at position 8 (L 8 P). The point mutations C 112 R and D 136 N in N pro have recently been shown to abate its capacity to degrade IRF-3 and prevent IFN-b promoter activation, as well as prevent the interaction of N pro with IRF-3 (Ruggli et al., 2009; Szymanski et al., 2009) . Similarly, N pro L 8 P does not antagonize IFN-a/b production (Gil et al., 2006) .
Western blots of whole-cell extracts revealed that N pro protein was barely detectable in the PK-15 cell lines individually expressing either the C 112 R or D 136 N N pro point mutant or wild-type N pro (Fig. 3a) . Likewise, the level of L 8 P N pro and wild-type N pro expressed in the 3T3 cell lines was low (Fig. 3b ). However, treatment with proteasome inhibitor led to an accumulation of both mutant and wild-type N pro in both cell types. In agreement, CHX assays using the PK-15 cell lines stably expressing C 112 R or D 136 N N pro confirmed that these proteins were degraded rapidly, like wild-type N pro , and were not stabilized by their inability to interact with IRF-3 ( Fig. 3c ). In fact, C 112 R and D 136 N N pro , particularly the former, appeared to be inherently less stable than wild-type N pro . The reasons for this are unclear, but may involve different protein conformations (Szymanski et al., 2009) .
Next, to determine whether the degradation of N pro is dependent on the level of IRF-3 within a cell, we utilized mouse embryonic fibroblasts (MEFs) in which the IRF-3 gene had been knocked out (2/2 IRF-3) (a gift from Tadatsugu Taniguchi, Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo, Japan) (Sato et al., 2000) . The inability of the 2/2 IRF-3 MEFs to express IRF-3 was first confirmed by Western blotting (Fig. 3d ). Stable transfections were then performed to generate 2/2 IRF-3 MEFs and control MEFs (derived from a +/+ IRF-3 littermate) that expressed N pro (Alfort strain). These were treated with proteasome inhibitor and whole-cell extracts were analysed by Western blotting. Fig. 3 (e) shows that N pro was only detectable in both +/+ and 2/2 IRF-3 MEFs after inhibition of the proteasome, confirming that N pro is still degraded rapidly in the absence of IRF-3. As the N pro -expressing MEFs were non-clonal, the higher level of N pro observed in the +/+ IRF-3 cells was most probably a result of variation in transfection efficiency. However, to further investigate the role of IRF-3 in N pro degradation, an IRF-3 small interfering RNA (siRNA) construct (InvivoGen) was utilized to generate stable N pro -expressing cell lines in which IRF-3 mRNA was targeted. A control siRNA construct (InvivoGen) was used as a negative control. Fig. 3 (f) confirms that IRF-3 protein levels were reduced considerably by the IRF-3 siRNA in both parental and N pro -expressing 3T3 cells. However, comparison of the N pro -expressing control and IRF-3 siRNA cell lines revealed no observable difference in N pro protein expression ( Fig. 3f) . These results confirm that the presence of IRF-3 does not stabilize N pro .
Here, we have provided biochemical evidence that N pro is an unstable protein that is degraded rapidly by the proteasome in a ubiquitin-dependent manner in PK-15, 3T3 and MEF stable cell lines and CSFV-infected PK-15 cells. CSFV translation produces a polyprotein and initially generates an equimolar quantity of viral proteins. It is feasible that N pro is susceptible to rapid degradation in order to regulate its cellular levels in both the nuclear and cytoplasmic compartments. This may also be the case for the core product of the related hepatitis C virus, the turnover of which occurs via both ubiquitin-dependent and -independent proteasome pathways (Shirakura et al., 2007; Suzuki et al., 2009) .
Like N pro , the rotavirus NSP1 product binds and targets IRF-3 for proteasomal degradation (Barro & Patton, 2005 Graff et al., 2002 Graff et al., , 2007 . NSP1 is also degraded in a proteasome-dependent manner, a property attributed to its proposed function as an E3 ubiquitin ligase (Graff et al., 2007) . Furthermore, NSP1's ability to degrade IRF-3 is independent of NSP1 proteasomal degradation (Sen et al., 2009) . It remains to be determined whether the CSFV N pro product targets IRF-3 via an intrinsic ubiquitin ligase activity or whether this function is mediated through a separate protein. N pro has recently been shown to contain a zinc-binding TRASH motif, but the authors suggest that this is unlikely to confer E3 ubiquitin ligase activity (Szymanski et al., 2009 ). This study placed particular emphasis on investigating the correlation between N pro and N pro -mediated IRF-3 turnover. We show that N pro is not degraded as a direct consequence of its ability to interact with and to target IRF-3 for ubiquitin-dependent proteasomal degradation. However, the data presented here show that an intact ubiquitin system is required for the turnover of N pro per se.
